GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Shiller PE Ratio

Lobe Sciences (XCNQ:LOBE) Shiller PE Ratio : (As of Mar. 25, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Lobe Sciences Shiller PE Ratio Historical Data

The historical data trend for Lobe Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Shiller PE Ratio Chart

Lobe Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lobe Sciences Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lobe Sciences's Shiller PE Ratio

For the Biotechnology subindustry, Lobe Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Shiller PE Ratio falls into.



Lobe Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lobe Sciences's E10 for the quarter that ended in Nov. 2024 is calculated as:

For example, Lobe Sciences's adjusted earnings per share data for the three months ended in Nov. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Nov. 2024 (Change)*Current CPI (Nov. 2024)
=0/127.8378*127.8378
=0.000

Current CPI (Nov. 2024) = 127.8378.

Lobe Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.000 98.367 0.000
201503 -0.028 99.789 -0.036
201506 -0.019 100.500 -0.024
201509 -0.020 100.421 -0.025
201512 -0.174 99.947 -0.223
201603 -0.015 101.054 -0.019
201606 -0.011 102.002 -0.014
201609 -0.020 101.765 -0.025
201612 -0.074 101.449 -0.093
201703 -0.013 102.634 -0.016
201706 -0.021 103.029 -0.026
201709 -0.012 103.345 -0.015
201712 -0.076 103.345 -0.094
201803 -0.017 105.004 -0.021
201806 -0.011 105.557 -0.013
201809 -0.021 105.636 -0.025
201812 -0.191 105.399 -0.232
201903 -0.060 106.979 -0.072
201908 -0.085 108.085 -0.101
201911 -0.060 107.769 -0.071
202002 -0.120 108.559 -0.141
202005 -0.060 107.532 -0.071
202008 -0.300 108.243 -0.354
202011 -0.060 108.796 -0.071
202102 -0.120 109.745 -0.140
202105 0.320 111.404 0.367
202108 -0.290 112.668 -0.329
202111 -0.120 113.932 -0.135
202202 -0.080 115.986 -0.088
202205 -0.050 120.016 -0.053
202208 -0.060 120.569 -0.064
202211 -0.030 121.675 -0.032
202302 -0.010 122.070 -0.010
202305 -0.003 124.045 -0.003
202308 -0.017 125.389 -0.017
202311 -0.010 125.468 -0.010
202402 -0.010 125.468 -0.010
202405 -0.003 127.601 -0.003
202408 -0.020 127.838 -0.020
202411 0.000 127.838 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Lobe Sciences  (XCNQ:LOBE) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Lobe Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences Business Description

Traded in Other Exchanges
Address
1771 Robson Street, No. 1614, Vancouver, BC, CAN, V6G 3B7
Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines